Steadymed ltd. (STDY)
Income statement / Yearly
Dec'17Dec'16Dec'15Dec'14
Revenues

1,065

1,065

869

-

Operating expenses:
Research and development

14,605

20,902

19,956

12,876

Sales and marketing

1,741

1,921

807

-

Marketing

-

-

-

928

General and administrative

5,154

5,640

4,791

1,996

Total operating expenses

21,500

28,463

25,554

-

Total operating loss

-20,435

-27,398

-24,685

-15,800

Financial expenses, net

-2,764

1,901

88

-2,995

Loss before taxes on income

-23,199

-25,497

-24,597

-18,795

Taxes on income

6

372

374

245

Net loss

-23,205

-25,869

-

-

Net loss

-

-

-24,971

-19,040

Net loss per share:
Basic and diluted net loss per Ordinary Share

-0.95

-1.59

-2.45

-44.15

Weighted average number of Ordinary Shares used in computing basic and diluted net loss per share

24,421

16,253

10,593

501